Family Care Hospitals (BOM:516110) Research & Development: ₹0.00 Mil (TTM As of Dec. 2025)


BOM:516110 Family Care Hospitals Ltd BOM:516110
29 GF Score
Price ₹2.91
GF Value ₹0.04
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Family Care Hospitals Research & Development?

Family Care Hospitals BOM:516110 -0.68% 29 Research & Development is ₹0.00 Mil as of Dec. 2025. GuruFocus rates BOM:516110 with a GF Score™ of 29/100 and a GF Value™ of ₹0.04 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Family Care Hospitals's Research & Development for the three months ended in Dec. 2025 was ₹0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was ₹0.00 Mil.

Family Care Hospitals  (BOM:516110) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Family Care Hospitals Research & Development Related Terms

Family Care Hospitals Research & Development Historical Data

* Premium members only.

The historical data trend for Family Care Hospitals's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Family Care Hospitals Research & Development Chart

Family Care Hospitals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Family Care Hospitals Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:516110
29GF Score
Family Care Hospitals Ltd BOM:516110
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Family Care Hospitals Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0.00 Mil mean?
Family Care Hospitals (BOM:516110) has a Research & Development of ₹0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Family Care Hospitals and its competitors.
Is Family Care Hospitals' Research & Development too high?
Family Care Hospitals' current Research & Development is ₹0.00 Mil. Overall, Family Care Hospitals has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Family Care Hospitals' Research & Development compare to HCA and THC?
Family Care Hospitals' Research & Development of ₹0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Family Care Hospitals and its competitors. Family Care Hospitals's current Research & Development is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Family Care Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Family Care Hospitals (BOM:516110) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹0.04, compared to a current price of ₹2.91 — trading 7175% above its estimated fair value. The current Research & Development is ₹0.00 Mil. Family Care Hospitals' overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Family Care Hospitals (BOM:516110), the current Research & Development is ₹0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Family Care Hospitals (BOM:516110) Overvalued in 2026?

Based on GuruFocus' analysis, Family Care Hospitals stock appears to be overvalued. The current stock price of ₹2.91 is trading 7175% above its estimated GF Value™ of ₹0.04. GuruFocus considers Family Care Hospitals to be Significantly Overvalued.

Key valuation signals for BOM:516110:

  • Research & Development: ₹0.00 Mil
  • GF Value™: ₹0.04 vs. price of ₹2.91 (7175% above fair value)
  • GF Score™: 29/100 with 6 warning signs

No single metric tells the full story. See the BOM:516110 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Family Care Hospitals Business Description

Address Road No. 26, Plot No. A357, Wagle Industrial Estate, MIDC, Thane (West), Thane, MH, IND, 400604
Family Care Hospitals Ltd is engaged in healthcare services. The company provides general surgeries, gynaecology, orthopedics, cardiology, urology, oncology, and others.
29GF Score

Get the complete analysis for BOM:516110

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2.91
Price
₹0.04
GF Value